Our results showed that neither C16 nor C18 ceramide pretreatment (10 nM) was able to prevent sortilin vascular effect, while pretreatment with aCDase siRNA protected from endothelial dysfunction induced by sortilin (Supplemental Figure 2, E and F). The gene discussed is SORT1; the disease is endothelial dysfunction.